Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
US-2015045515-A1 · Feb 12, 2015 · US
US11452291B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11452291-B2 |
| Application number | US-202015931561-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2020 |
| Priority date | May 14, 2007 |
| Publication date | Sep 27, 2022 |
| Grant date | Sep 27, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One aspect of the present invention is directed to a composition. The composition includes a dispersion inducer comprising:H3C—(CH2)n—CHmCHmR,where is a single or double carbon-carbon bond, m is 1 or 2, n is 2 to 15, and R is a carboxylic acid, a salt, an ester, or an amide, where the ester or amide is an isostere or biostere of the carboxylic acid. The composition additionally contains an additive component selected from one or more of the group consisting of biocides, surfactants, antibiotics, antiseptics, detergents, chelating agents, virulence factor inhibitors, gels, polymers, pastes, edible products, and chewable products. The composition is formulated so that when it is contacted with a biofilm produced by a microorganism, where the biofilm comprises a matrix and microorganism on a surface, the dispersion inducer selectively acts on the microorganism and has a suitable biological response without a required direct effect on the matrix to disperse the biofilm. The present invention is also directed to methods of using this compound.
Opening claim text (preview).
The invention claimed is: 1. A medical device or dressing, comprising: cis-2-decenoic acid at a concentration of 0.001 μM to 30 μM; and a support configured to release the cis-2-decenoic acid over a length of time. 2. The medical device or dressing of claim 1 , wherein the cis-2-decenoic acid is at a concentration of 1 μM to 30 μM. 3. The medical device or dressing according to claim 1 , wherein the support comprises cotton. 4. The medical device or dressing according to claim 1 , wherein the support comprises a polymer selected from the group consisting of a polyamide, a polyester, a polypropylene, a polytetrafluoroethylene, a copolymer, and cellulose. 5. The medical device or dressing according to claim 1 , wherein the support comprises a gel. 6. The medical device or dressing of claim 1 , wherein the medical device or dressing is selected from the group consisting of: an indwelling medical device, a catheter; a respirator, a ventilator; a stent; an artificial valve; a joint; a pin; a bone implant, a suture; a staple; and a pacemaker. 7. The medical device or dressing of claim 5 , wherein the gel is provided as a coating on a fiber. 8. The medical device or dressing of claim 1 , wherein the medical device or dressing is a topical dressing. 9. The medical device or dressing of claim 1 , wherein the medical device or dressing is non-bacteriocidal. 10. The medical device or dressing of claim 1 , wherein the support is a provided as a coating. 11. A coating for a medical device or dressing, comprising: a polymer or a gel formulated to coat a medical device or dressing, containing cis-2-decenoic acid in a concentration of 0.001 μM to 30 μM, the polymer or gel being configured to prolong a release of the cis-2-decenoic acid with respect to an absence of the polymer or gel, to induce a biological dispersion induction response of a biofilm containing a microorganism exposed to the cis-2-decenoic acid. 12. A biofilm disperser for a medical device or dressing, comprising: cis-2-decenoic acid in a concentration of 0.001 μM to 30 μM; and a gel or polymer configured to release the cis-2-decenoic acid over a length of time. 13. The biofilm disperser according to claim 12 , wherein the the gel or polymer comprises a gel. 14. The biofilm disperser according to claim 12 , further comprising a biocide. 15. The biofilm disperser according to claim 12 , wherein the medical device is selected from the group consisting of a catheter, a ventilator, and a respirator. 16. The biofilm disperser according to claim 12 , wherein the medical device comprises a bone implant. 17. The biofilm disperser according to claim 12 , further comprising at least one of a biocide and an antibiotic. 18. The medical device or dressing according to claim 1 , wherein the medical device or dressing comprises an implantable medical device. 19. The medical device or dressing according to claim 1 , wherein the medical device or dressing comprises a suture or surgical staple. 20. The coating for a medical device or dressing according to claim 11 , wherein the medical device or dressing is selected from the group consisting of: an indwelling medical device, a catheter; a respirator, a ventilator; a stent; an artificial valve; a joint; a pin; a bone implant, a suture; a staple; and a pacemaker.
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
for disorders of the vagina · CPC title
of the prostate · CPC title
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof · CPC title
Drugs for dermatological disorders · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.